Accumulating nanoparticles by EPR: A route of no return-Reference-Cited by-同舟云学术

Accumulating nanoparticles by EPR: A route of no return

Published:2016-09 Issue: Volume:238 Page:58-70
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Ngoune Romeo^ORCID,Peters Annette,von Elverfeldt Dominik,Winkler Karl,Pütz Gerhard^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs;Matsumura;Cancer Res.,1986

2. A retrospective 30years after discovery of the enhanced permeability and retention effect of solid tumors: next-generation chemotherapeutics and photodynamic therapy—problems, solutions, and prospects;Maeda;Microcirculation,2016

3. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond;Maeda;J. Control. Release,2012

4. Anticancer nanomedicine and tumor vascular permeability; where is the missing link?;Taurin;J. Control. Release,2012

5. Openings between defective endothelial cells explain tumor vessel leakiness;Hashizume;Am. J. Pathol.,2000

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: an emerging modality for treating breast cancer;Cancer Nanotechnology;2024-07-20

2. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17

3. A Concise Review on Effect of PEGylation on the Properties of Lipid-Based Nanoparticles;ASSAY and Drug Development Technologies;2024-07-01

4. Herbal Medicine-Derived Exosome-Like Nanovesicles: A Rising Star in Cancer Therapy;International Journal of Nanomedicine;2024-07

5. Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery Systems;Current Pharmaceutical Biotechnology;2024-06-20